nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprostadil—Injection site haematoma—Octreotide—thymus cancer	0.0913	0.127	CcSEcCtD
Alprostadil—Pain localised—Octreotide—thymus cancer	0.0747	0.104	CcSEcCtD
Alprostadil—PTGIR—pulmonary artery—thymus cancer	0.0679	0.244	CbGeAlD
Alprostadil—Flu symptoms—Octreotide—thymus cancer	0.0496	0.0689	CcSEcCtD
Alprostadil—Prostatitis—Octreotide—thymus cancer	0.0394	0.0547	CcSEcCtD
Alprostadil—Diabetic—Octreotide—thymus cancer	0.0258	0.0358	CcSEcCtD
Alprostadil—Hypochromic anaemia—Octreotide—thymus cancer	0.0222	0.0308	CcSEcCtD
Alprostadil—Prostatic disorder—Octreotide—thymus cancer	0.0203	0.0281	CcSEcCtD
Alprostadil—Trauma—Octreotide—thymus cancer	0.0181	0.0251	CcSEcCtD
Alprostadil—Local reaction—Octreotide—thymus cancer	0.0156	0.0216	CcSEcCtD
Alprostadil—Multiple fractures—Octreotide—thymus cancer	0.0148	0.0205	CcSEcCtD
Alprostadil—Fracture—Octreotide—thymus cancer	0.0148	0.0205	CcSEcCtD
Alprostadil—Haematoma—Octreotide—thymus cancer	0.0137	0.019	CcSEcCtD
Alprostadil—Redness—Octreotide—thymus cancer	0.0128	0.0177	CcSEcCtD
Alprostadil—Burning sensation—Octreotide—thymus cancer	0.0124	0.0172	CcSEcCtD
Alprostadil—SLCO2A1—neck—thymus cancer	0.0123	0.044	CbGeAlD
Alprostadil—Influenza-like symptoms—Octreotide—thymus cancer	0.0121	0.0167	CcSEcCtD
Alprostadil—PTGER2—bone marrow—thymus cancer	0.0114	0.041	CbGeAlD
Alprostadil—Injection site pain—Octreotide—thymus cancer	0.0105	0.0146	CcSEcCtD
Alprostadil—PTGIR—hematopoietic system—thymus cancer	0.0104	0.0375	CbGeAlD
Alprostadil—Numbness—Octreotide—thymus cancer	0.0104	0.0144	CcSEcCtD
Alprostadil—PTGER2—lung—thymus cancer	0.0104	0.0371	CbGeAlD
Alprostadil—Sensory loss—Octreotide—thymus cancer	0.00994	0.0138	CcSEcCtD
Alprostadil—PTGIR—epithelium—thymus cancer	0.00955	0.0342	CbGeAlD
Alprostadil—Hyperbilirubinaemia—Octreotide—thymus cancer	0.00947	0.0131	CcSEcCtD
Alprostadil—Injection site reaction—Octreotide—thymus cancer	0.00856	0.0119	CcSEcCtD
Alprostadil—Hyperkalaemia—Octreotide—thymus cancer	0.00846	0.0117	CcSEcCtD
Alprostadil—Influenza like illness—Octreotide—thymus cancer	0.00836	0.0116	CcSEcCtD
Alprostadil—Wheezing—Octreotide—thymus cancer	0.00836	0.0116	CcSEcCtD
Alprostadil—SLCO2A1—epithelium—thymus cancer	0.00835	0.0299	CbGeAlD
Alprostadil—Cramps of lower extremities—Octreotide—thymus cancer	0.00791	0.011	CcSEcCtD
Alprostadil—Diabetes mellitus—Octreotide—thymus cancer	0.00719	0.00997	CcSEcCtD
Alprostadil—PTGER2—lymph node—thymus cancer	0.00709	0.0254	CbGeAlD
Alprostadil—SLCO3A1—cardiac atrium—thymus cancer	0.007	0.0251	CbGeAlD
Alprostadil—SLCO2A1—cardiac atrium—thymus cancer	0.00694	0.0249	CbGeAlD
Alprostadil—Cardiac failure congestive—Octreotide—thymus cancer	0.00689	0.00956	CcSEcCtD
Alprostadil—Nasal congestion—Octreotide—thymus cancer	0.00686	0.00952	CcSEcCtD
Alprostadil—SLCO3A1—pituitary gland—thymus cancer	0.00684	0.0245	CbGeAlD
Alprostadil—Injury—Octreotide—thymus cancer	0.0068	0.00943	CcSEcCtD
Alprostadil—SLCO2A1—pituitary gland—thymus cancer	0.00678	0.0243	CbGeAlD
Alprostadil—PTGIR—thyroid gland—thymus cancer	0.00668	0.024	CbGeAlD
Alprostadil—SLCO2B1—hematopoietic system—thymus cancer	0.00654	0.0234	CbGeAlD
Alprostadil—Hypoglycaemia—Octreotide—thymus cancer	0.00641	0.00888	CcSEcCtD
Alprostadil—ABCC5—cardiac atrium—thymus cancer	0.00634	0.0227	CbGeAlD
Alprostadil—Pain in extremity—Octreotide—thymus cancer	0.00625	0.00867	CcSEcCtD
Alprostadil—ABCC5—pituitary gland—thymus cancer	0.0062	0.0222	CbGeAlD
Alprostadil—PTGIR—lung—thymus cancer	0.00607	0.0218	CbGeAlD
Alprostadil—SLCO3A1—thyroid gland—thymus cancer	0.0059	0.0211	CbGeAlD
Alprostadil—SLCO2A1—thyroid gland—thymus cancer	0.00584	0.0209	CbGeAlD
Alprostadil—ABCC4—hematopoietic system—thymus cancer	0.00579	0.0208	CbGeAlD
Alprostadil—Influenza—Octreotide—thymus cancer	0.0054	0.00749	CcSEcCtD
Alprostadil—SLCO3A1—lung—thymus cancer	0.00536	0.0192	CbGeAlD
Alprostadil—ABCC5—bone marrow—thymus cancer	0.00536	0.0192	CbGeAlD
Alprostadil—ABCC5—thyroid gland—thymus cancer	0.00534	0.0191	CbGeAlD
Alprostadil—SLCO2A1—lung—thymus cancer	0.0053	0.019	CbGeAlD
Alprostadil—Sweating increased—Octreotide—thymus cancer	0.00526	0.0073	CcSEcCtD
Alprostadil—Bronchitis—Octreotide—thymus cancer	0.0052	0.00721	CcSEcCtD
Alprostadil—Upper respiratory tract infection—Octreotide—thymus cancer	0.00502	0.00696	CcSEcCtD
Alprostadil—Pollakiuria—Octreotide—thymus cancer	0.00499	0.00692	CcSEcCtD
Alprostadil—Hyperglycaemia—Octreotide—thymus cancer	0.00487	0.00676	CcSEcCtD
Alprostadil—ABCC5—lung—thymus cancer	0.00485	0.0174	CbGeAlD
Alprostadil—Urinary tract infection—Octreotide—thymus cancer	0.00468	0.00649	CcSEcCtD
Alprostadil—Haematuria—Octreotide—thymus cancer	0.00459	0.00637	CcSEcCtD
Alprostadil—Sinusitis—Octreotide—thymus cancer	0.00452	0.00627	CcSEcCtD
Alprostadil—Bradycardia—Octreotide—thymus cancer	0.0044	0.00611	CcSEcCtD
Alprostadil—Rhinitis—Octreotide—thymus cancer	0.00434	0.00601	CcSEcCtD
Alprostadil—Hypoaesthesia—Octreotide—thymus cancer	0.0043	0.00597	CcSEcCtD
Alprostadil—Pharyngitis—Octreotide—thymus cancer	0.00429	0.00595	CcSEcCtD
Alprostadil—SLCO2B1—thyroid gland—thymus cancer	0.00418	0.015	CbGeAlD
Alprostadil—Visual impairment—Octreotide—thymus cancer	0.00417	0.00578	CcSEcCtD
Alprostadil—PTGIR—lymph node—thymus cancer	0.00415	0.0149	CbGeAlD
Alprostadil—Flushing—Octreotide—thymus cancer	0.00401	0.00557	CcSEcCtD
Alprostadil—SLCO2B1—lung—thymus cancer	0.0038	0.0136	CbGeAlD
Alprostadil—Erythema—Octreotide—thymus cancer	0.00376	0.00522	CcSEcCtD
Alprostadil—ABCC4—bone marrow—thymus cancer	0.00371	0.0133	CbGeAlD
Alprostadil—ABCC4—thyroid gland—thymus cancer	0.0037	0.0133	CbGeAlD
Alprostadil—SLCO3A1—lymph node—thymus cancer	0.00366	0.0131	CbGeAlD
Alprostadil—Nervousness—Octreotide—thymus cancer	0.00366	0.00507	CcSEcCtD
Alprostadil—Back pain—Octreotide—thymus cancer	0.00364	0.00505	CcSEcCtD
Alprostadil—SLCO2A1—lymph node—thymus cancer	0.00363	0.013	CbGeAlD
Alprostadil—Muscle spasms—Octreotide—thymus cancer	0.00362	0.00502	CcSEcCtD
Alprostadil—Anaemia—Octreotide—thymus cancer	0.00348	0.00483	CcSEcCtD
Alprostadil—Syncope—Octreotide—thymus cancer	0.00338	0.00468	CcSEcCtD
Alprostadil—ABCC4—lung—thymus cancer	0.00336	0.0121	CbGeAlD
Alprostadil—ABCC5—lymph node—thymus cancer	0.00332	0.0119	CbGeAlD
Alprostadil—Loss of consciousness—Octreotide—thymus cancer	0.00331	0.00459	CcSEcCtD
Alprostadil—Cough—Octreotide—thymus cancer	0.00328	0.00456	CcSEcCtD
Alprostadil—Convulsion—Octreotide—thymus cancer	0.00326	0.00452	CcSEcCtD
Alprostadil—Hypertension—Octreotide—thymus cancer	0.00325	0.00451	CcSEcCtD
Alprostadil—Discomfort—Octreotide—thymus cancer	0.00317	0.00439	CcSEcCtD
Alprostadil—Dry mouth—Octreotide—thymus cancer	0.00313	0.00435	CcSEcCtD
Alprostadil—Oedema—Octreotide—thymus cancer	0.00307	0.00426	CcSEcCtD
Alprostadil—Infection—Octreotide—thymus cancer	0.00305	0.00423	CcSEcCtD
Alprostadil—Shock—Octreotide—thymus cancer	0.00302	0.00419	CcSEcCtD
Alprostadil—Thrombocytopenia—Octreotide—thymus cancer	0.00301	0.00417	CcSEcCtD
Alprostadil—Tachycardia—Octreotide—thymus cancer	0.003	0.00416	CcSEcCtD
Alprostadil—Skin disorder—Octreotide—thymus cancer	0.00298	0.00414	CcSEcCtD
Alprostadil—Hyperhidrosis—Octreotide—thymus cancer	0.00297	0.00412	CcSEcCtD
Alprostadil—Dyspepsia—Octreotide—thymus cancer	0.0027	0.00375	CcSEcCtD
Alprostadil—Pain—Octreotide—thymus cancer	0.00263	0.00364	CcSEcCtD
Alprostadil—SLCO2B1—lymph node—thymus cancer	0.0026	0.00931	CbGeAlD
Alprostadil—Feeling abnormal—Octreotide—thymus cancer	0.00253	0.00351	CcSEcCtD
Alprostadil—Abdominal pain—Octreotide—thymus cancer	0.00243	0.00337	CcSEcCtD
Alprostadil—Body temperature increased—Octreotide—thymus cancer	0.00243	0.00337	CcSEcCtD
Alprostadil—ABCC4—lymph node—thymus cancer	0.0023	0.00824	CbGeAlD
Alprostadil—Asthenia—Octreotide—thymus cancer	0.0022	0.00306	CcSEcCtD
Alprostadil—Pruritus—Octreotide—thymus cancer	0.00217	0.00301	CcSEcCtD
Alprostadil—Diarrhoea—Octreotide—thymus cancer	0.0021	0.00292	CcSEcCtD
Alprostadil—Dizziness—Octreotide—thymus cancer	0.00203	0.00282	CcSEcCtD
Alprostadil—Rash—Octreotide—thymus cancer	0.00194	0.00269	CcSEcCtD
Alprostadil—Dermatitis—Octreotide—thymus cancer	0.00194	0.00268	CcSEcCtD
Alprostadil—Headache—Octreotide—thymus cancer	0.00192	0.00267	CcSEcCtD
Alprostadil—Nausea—Octreotide—thymus cancer	0.00182	0.00253	CcSEcCtD
